Legal Framework for the Use of Psychedelics in Switzerland
Cannabis Law Report
JULY 24, 2022
analyse the history and applications of psychedelic substances such as LSD, psilocybin, MDMA and mescaline. The market launch of drugs containing MDMA for post-traumatic stress disorder (PTSD) or psilocybin for the treatment of depression is expected in the next five to ten years [1]. ruling BVGer C-4592/2019).
Let's personalize your content